Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
作者信息
Zimmer Vincent, Lammert Frank
机构信息
Department of Medicine II, Saarland University Medical Center, Homburg, Germany.
出版信息
EBioMedicine. 2017 Feb;15:10-11. doi: 10.1016/j.ebiom.2016.12.008. Epub 2016 Dec 15.
Abstract
摘要
相似文献
1
Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.展望未来：预测原发性胆汁性胆管炎对熊去氧胆酸无反应的情况。
EBioMedicine. 2017 Feb;15:10-11. doi: 10.1016/j.ebiom.2016.12.008. Epub 2016 Dec 15.
2
Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.熊去氧胆酸治疗原发性硬化性胆管炎
Ital J Gastroenterol. 1996 Apr;28(3):178-80.
3
Primary sclerosing cholangitis: updates in diagnosis and therapy.原发性硬化性胆管炎：诊断与治疗的进展
World J Gastroenterol. 2005 Jan 7;11(1):7-16. doi: 10.3748/wjg.v11.i1.7.
4
Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.孕期原发性硬化性胆管炎对熊去氧胆酸治疗无效：一例报告
J Reprod Med. 2010 Nov-Dec;55(11-12):517-9.
5
[Treatment of cholestatic liver diseases with ursodeoxycholic acid].用熊去氧胆酸治疗胆汁淤积性肝病
Tidsskr Nor Laegeforen. 1997 Sep 30;117(23):3370-3.
6
The medical management of primary sclerosing cholangitis.原发性硬化性胆管炎的药物治疗
Semin Liver Dis. 2006 Feb;26(1):52-61. doi: 10.1055/s-2006-933563.
7
[Primary biliary cirrhosis. Primary sclerosing cholangitis].[原发性胆汁性肝硬化。原发性硬化性胆管炎]
Gastroenterol Clin Biol. 2003 Mar;27(3 Pt 1):325-32.
8
Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.用熊去氧胆酸对原发性硬化性胆管炎进行药物治疗。
Dig Liver Dis. 2003 May;35(5):306-8. doi: 10.1016/s1590-8658(03)00072-0.
9
URSO not so good for PSC.熊去氧胆酸对原发性硬化性胆管炎效果欠佳。
Inflamm Bowel Dis. 1998 May;4(2):172-3. doi: 10.1002/ibd.3780040215.
10
[Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].[自身免疫性胆汁淤积综合征。熊去氧胆酸是药物标准]
MMW Fortschr Med. 2007 May 24;149(21):49.
引用本文的文献
1
The role of HLA-G in primary biliary cholangitis and response to therapy.HLA-G在原发性胆汁性胆管炎中的作用及对治疗的反应。
Front Immunol. 2025 Jul 29;16:1585535. doi: 10.3389/fimmu.2025.1585535. eCollection 2025.
本文引用的文献
1
Early Molecular Stratification of High-risk Primary Biliary Cholangitis.高危原发性胆汁性胆管炎的早期分子分层
EBioMedicine. 2016 Dec;14:65-73. doi: 10.1016/j.ebiom.2016.11.021. Epub 2016 Nov 21.
2
Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.原发性胆汁性胆管炎患者血清可溶性CD14和IL-8水平与临床结局的相关性
Liver Int. 2017 Jun;37(6):897-905. doi: 10.1111/liv.13316. Epub 2016 Dec 6.
3
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.奥贝胆酸治疗原发性胆汁性胆管炎的安慰剂对照临床试验。
N Engl J Med. 2016 Aug 18;375(7):631-43. doi: 10.1056/NEJMoa1509840.
4
Genome-Wide Association Studies in Primary Biliary Cirrhosis.原发性胆汁性肝硬化的全基因组关联研究
Semin Liver Dis. 2015 Nov;35(4):392-401. doi: 10.1055/s-0035-1567831. Epub 2015 Dec 16.
5
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.原发性胆汁性肝硬化患者接受熊去氧胆酸治疗结局预测评分系统的建立与验证。
Gastroenterology. 2015 Dec;149(7):1804-1812.e4. doi: 10.1053/j.gastro.2015.07.061. Epub 2015 Aug 7.
6
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.英国原发性胆汁性胆管炎风险评分：原发性胆汁性胆管炎终末期肝病长期预测评分系统的推导与验证
Hepatology. 2016 Mar;63(3):930-50. doi: 10.1002/hep.28017. Epub 2015 Oct 20.
7
The association between bile salt export pump single-nucleotide polymorphisms and primary biliary cirrhosis susceptibility and ursodeoxycholic acid response.胆盐输出泵单核苷酸多态性与原发性胆汁性肝硬化易感性及熊去氧胆酸反应之间的关联。
Dis Markers. 2014;2014:350690. doi: 10.1155/2014/350690. Epub 2014 Oct 19.
8
Unmet clinical need in autoimmune liver diseases.自身免疫性肝病的未满足临床需求。
J Hepatol. 2015 Jan;62(1):208-18. doi: 10.1016/j.jhep.2014.09.010. Epub 2014 Sep 16.
9
Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study.熊去氧胆酸对原发性胆汁性肝硬化的早期生化应答与长期预后：一项 14 年队列研究的结果。
Hepatology. 2013 Jul;58(1):264-72. doi: 10.1002/hep.26322. Epub 2013 May 27.
10
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid.性别和年龄是原发性胆汁性肝硬化临床表型和熊去氧胆酸反应的决定因素。
Gastroenterology. 2013 Mar;144(3):560-569.e7; quiz e13-4. doi: 10.1053/j.gastro.2012.12.005. Epub 2012 Dec 12.
Zotero 插件